Last reviewed · How we verify

NCT05220371

Influence of Specific Collagen Peptides on Recovery After Exercise Induced Muscle Damage

Completed NA Last updated 28 August 2023
What this trial tests

NA trial testing Collagen in Recovery in 50 participants. Completed in 30 June 2023.

Timeline
28 January 2022
Primary endpoint
30 June 2023
30 June 2023

Quick facts

Lead sponsorUniversity of Vienna
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment50
Start date28 January 2022
Primary completion30 June 2023
Estimated completion30 June 2023
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

University of Vienna

Who can join

Adults 18 to 40, male only, with Recovery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims at investigating the potential influence of specific collagen peptides on recovery after exercise induced muscle damage with focus on long-term effects.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Reduction in systemic muscle stress markers after exercise-induced muscle damage following concurrent training and supplementation with specific collagen peptides - a randomized controlled trial.
    Bischof K, Stafilidis S, Bundschuh L, Oesser S, et al · · 2024 · cited 6× · PMID 38590831 · DOI 10.3389/fnut.2024.1384112
  2. Influence of specific collagen peptides and 12-week concurrent training on recovery-related biomechanical characteristics following exercise-induced muscle damage-A randomized controlled trial.
    Bischof K, Stafilidis S, Bundschuh L, Oesser S, et al · · 2023 · cited 5× · PMID 38035363 · DOI 10.3389/fnut.2023.1266056

Verify or expand the search:

Other trials of Collagen

Trials testing the same drug.

Other recruiting trials for Recovery

Currently open trials in the same condition.

Other University of Vienna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05220371.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing